UnitedHealth Group (UNH) Shares Climb 8.5% on Medicare Advantage Payment Boost

UnitedHealth Group shares rose 8.5% to $305.36 on 25 October 2025, marking a significant intraday gain for the US healthcare giant. The move followed a larger-than-expected Medicare Advantage payment increase, boosting investor confidence.

Medicare Advantage Payment Boost

The Trump administration and the Centers for Medicare and Medicaid Services (CMS) finalised a more substantial Medicare Advantage payment increase than anticipated. This development directly benefits UnitedHealth Group, which operates extensive Medicare Advantage plans, by improving the outlook for its profit margins. The previous close for UNH was $281.36.

The positive regulatory news arrives as the broader healthcare sector navigates evolving policy landscapes and demographic shifts. This specific policy adjustment provides a clear tailwind for insurers heavily invested in government-backed health programmes.

Analyst Upgrades and Q3 Optimism

Reinforcing the positive sentiment, Jefferies raised its price target for UnitedHealth Group to $409, citing improved margins and strength within the Medicare segment. This analyst action, reported on 25 October 2025, coincided with a Weiss Ratings upgrade for UNH from "sell" to "hold". Furthermore, bullish previews for the company's third-quarter earnings highlighted favourable premium trends and opportunities within its Optum division. These factors collectively outweighed neutral artificial intelligence initiatives and the recent departure of Optum's chief financial officer, contributing to the elevated trading volume ahead of the Q3 results.